PNC Financial Services Group’s Rosetta Genomics Ltd. ROSG Stock Holding History

PNC Financial Services Group’s Portfolio ROSG Stock Details ROSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-14	Closed	–	–	4537
2016 Q2	$0	Buy	+14	New	+$199	﹤0.01%	4624

Other funds holding ROSG

HCM

Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

PNC Financial Services Group's ROSG Position: Q3 2016 in Review

PNC Financial Services Group sold out of Rosetta Genomics Ltd. (ROSG) in Q3 2016, closing a stake of 14 shares.

PNC Financial Services Group first reported a position in ROSG in Q2 2016 and held it in 1 quarter. The position peaked at $0 in Q2 2016. 8 funds tracked by Wall St. Rank hold ROSG as of Q3 2016.

PNC Financial Services Group reported no remaining Rosetta Genomics Ltd. position as of Q3 2016 after selling out during the quarter.
PNC Financial Services Group sold 14 Rosetta Genomics Ltd. shares in Q3 2016.
PNC Financial Services Group first reported a position in Rosetta Genomics Ltd. in Q2 2016 and held it in 1 quarter.
PNC Financial Services Group's Rosetta Genomics Ltd. position peaked at $0 in Q2 2016.
8 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q3 2016.

Based on PNC Financial Services Group's 13F filing for Q3 2016, filed 4 Nov 2016.